Microcurrent stimulation for macular degeneration treatment

Conclusion: The substantial changes observed over this period, combined with continued improvement for patients who continued treatment once a month, are encouraging for future studies. Read this original research and sign up to receive Clinical Ophthalmology journal here: https://www.dovepress.com/articles.php?article_id=25016
Figure 1 Patient receiving microcurrent treatment.

Figure 1 Patient receiving microcurrent treatment.

Figure 2 Dry AMD eyes: absolute logMAR differences from starting values for each patient, plotted over first 3 months only.

Figure 2 Dry AMD eyes: absolute logMAR differences from starting values for each patient, plotted over first 3 months only.

Figure 3 Wet AMD eyes: absolute logMAR differences from starting values for each patient, plotted over first 3 months only.

Figure 3 Wet AMD eyes: absolute logMAR differences from starting values for each patient, plotted over first 3 months only.

Figure 4 Dry AMD eyes: mean absolute logMAR differences from starting values with 95% confidence intervals on these means.

Figure 4 Dry AMD eyes: mean absolute logMAR differences from starting values with 95% confidence intervals on these means.

Figure 5 Wet AMD eyes: mean absolute logMAR differences from starting values with 95% confidence intervals on these means.

Figure 5 Wet AMD eyes: mean absolute logMAR differences from starting values with 95% confidence intervals on these means.

Figure 6 Dry AMD eyes: total letter change.

Figure 6 Dry AMD eyes: total letter change.

Figure 7 Wet AMD eyes: total letter change.

Figure 7 Wet AMD eyes: total letter change.

Figure 8 Pre- and post-microperimetry fields on three patients.

Figure 8 Pre- and post-microperimetry fields on three patients.

Figure 9 Pre- and post-microperimtery fields on two patients.

Figure 9 Pre- and post-microperimtery fields on two patients.

Pinterest
Search